SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Cited by (785)

Items 501–600 of 785

1. Intrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its components
   N. El-Baky, A. Amara, V. Uversky, E. Redwan · 2023 · Journal of Cellular Biochemistry
2. Understanding how transmembrane domains regulate interactions between human BST-2 and the SARS-CoV-2 accessory protein ORF7a
   Madison M. Mann, Min-Kang Hsieh, James D Tang, William S. Hart, Matthew J. Lazzara, Jeffery B. Klauda, B. Berger · 2023 · Biochimica et Biophysica Acta - Biomembranes
3. Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene
   N. Tailor, B. Warner, B. Griffin, Kevin Tierney, E. Moffat, Kathy L. Frost, Robert Vendramelli, A. Leung, Marnie Willman, Sylvia P. Thomas et al. · 2022 · Viruses
4. Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations
   Gabrielle Gimenes Lima, A. Portilho, E. D. De Gaspari · 2022 · Pathogens
5. Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
   Cheng-Siang Tan, V. Noni, Whilemena Upam Herman Ulok Melina, Ummi Syafiqah Abdorahman, Joseph Niler Bimbang, Natasya Marliana Abdul Malik, M. Hossen, Md. Mizanur Rahman, L. Su'ut, Asri Said et al. · 2022 · Scientific Reports
6. B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates
   Yu Bai, Qian He, Jinghuan Yang, Shuai-Yao Lu, Qun-Ying Mao, Fan Gao, Lian-Lian Bian, Jialu Zhang, Chaoqiang An, Jianyang Liu et al. · 2022 · Microbiology spectrum
7. Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species
   A. Fears, B. Beddingfield, Nicole R. Chirichella, Nadia Slisarenko, S. Killeen, R. Redmann, K. Goff, Skye Spencer, Breanna Picou, Nadia A. Golden et al. · 2022 · PLoS Pathogens
8. Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants
   Minchao Li, Jiao-Shan Chen, Yajie Liu, Jin Zhao, Yan-Jun Li, Yunqi Hu, Yaoqing Chen, Li-Tao Sun, Yuelong Shu, Fengling Feng et al. · 2022 · Antiviral Research
9. COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
   Paola Stefanelli, Giovanni Rezza · 2022 · Vaccines
10. SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity
    Marta Baselga, A. Güemes, J. Alba, A. J. Schuhmacher · 2022 · Journal of Clinical Medicine
11. Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay
    Alanoud Alshami, Rabab A. Al Attas, Hadeel Anan, Aroub Al Maghrabi, Salim S. Ghandorah, Amani Mohammed, Abdulbary Ali Alhalimi, Jumana Mansour Al-Jishi, Hadi Alqahtani · 2021 · Frontiers in Microbiology
12. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
    S. Mohandas, P. Yadav, A. Shete, Dimpal A. Nyayanit, R. Jain, G. Sapkal, C. Mote · 2021 · bioRxiv
13. SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
    Ziwei Li, Jing Liu, Hui-Hong Deng, Xuecheng Yang, Hua Wang, Xuemei Feng, Gennadiy Zelinskyy, M. Trilling, K. Sutter, Meng-Ji Lu et al. · 2020 · bioRxiv
14. 2.5 Million Person-Years of Life Have Been Lost Due to COVID-19 in the United States
    S. Elledge · 2020 · medRxiv
15. Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein
    D. Muraoka, Si-Tuo Deng, S. Sawada, K. Akiyoshi, N. Harada, H. Ikeda · 2020 · Vaccine
16. SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques
    Sonny R. Elizaldi, Y. S. Lakshmanappa, Jamin W. Roh, B. Schmidt, Timothy D. Carroll, Kourtney D. Weaver, Justin C. Smith, J. Deere, Joseph C. Dutra, M. Stone et al. · 2020 · bioRxiv
17. Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques
    X. Alvarez, K. Sestak, S. Byrareddy, Mahesh Mohan · 2020 · Viruses
18. Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR)
    L. Mermel · 2020 · Infection control and hospital epidemiology
19. SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9
    Yingshu Luo, Zhen-Ling Zhang, Jiangnan Ren, Chunxu Dou, Jiancheng Wen, Yang Yang, Xiao-Feng Li, Zhixiang Yan, Yanzhi Han · 2024 · Frontiers in Immunology
20. Preclinical animal models to evaluate therapeutic antiviral antibodies.
    Amse De Meyer, P. Meuleman · 2024 · Antiviral Research
21. Investigation and long‐term monitoring of the presence of neutralizing antibody in patients with COVID‐19 disease of different clinical severity
    S. Kaygusuz, G. Korukluoglu, Y. Coşgun, Ömer Şahin, F. Arslan · 2022 · Journal of Medical Virology
22. SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review
    J. A. Malik, Mir Aroosa, Sakeel Ahmed, M. Shinde, S. Alghamdi, Khaled Almansour, Turki Al Hagbani, Muteb S. Alanazi, Sirajudheen Anwar · 2022 · Journal of Infection and Public Health
23. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
    D. Singh, E. Aladyeva, Shibali Das, Bindu Singh, E. Esaulova, A. Swain, Mushtaq Ahmed, Journey Cole, Chivonne Moodley, S. Mehra et al. · 2022 · Nature Communications
24. Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage
    Green Kim, D. H. Kim, H. Oh, Seongman Bae, Ji-Soo Kwon, Min-Jae Kim, Eunyoung Lee, Eun-Ha Hwang, Hoyin Jung, Bon-Sang Koo et al. · 2021 · Journal of Infectious Diseases
25. ChAdOx1 nCoV-19 (AZD1222) Vaccine in People Living With and Without HIV
    S. Madhi, A. Koen, L. Fairlie, C. Cutland, V. Baillie, S. Padayachee, K. Dheda, S. Barnabas, Q. Bhorat, Carmen Briner et al. · 2021 · Research Square
26. Estimating the impact of public health strategies on the spread of SARS‐CoV‐2: Epidemiological modelling for Toulouse, France
    Chloé Dimeglio, Marcel Miédougé, Jean–Michel Loubes, Jean‐Michel Mansuy, Jacques Izopet · 2021 · Reviews in Medical Virology
27. COVID-19 Reinfection in An Immunosuppressed Patient Without An Antibody Response
    Hillary P. Hunsinger, Gurusaravanan Kutti Sridharan, Venkata R. P. Rokkam, Lori E. Fantry · 2021 · American Journal of the Medical Sciences
28. Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19
    William P. Hausdorff, J. Flores · 2020 · International Journal of Infectious Diseases
29. Human Embryonic Stem Cell-derived Lung Organoids: a Model for SARS-CoV-2 Infection and Drug Test
    R. Pei, Jian-Qi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, Jiang-Ping He, Shuqi Xiao, Jin Xiong, Ying Lin et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
30. Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
    Gebre, Makda S., Rauch, Susanne, Roth, Nicole, Yu, Jingyou, Chandrashekar, Abishek, Mercado, Noe B., He, Xuan, Liu, Jinyan, McMahan, Katherine, Martinot, Amanda et al. · 2021
31. Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris
    Tongxin Zhao, Sheng Liu, Pengyan Wang, Yanfang Zhang, Xinrui Kang, X. Pan, Lin-Jie Li, Dedong Li, Ping Gao, Yaling An et al. · 2024 · PLoS Pathogens
32. Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates
    Celine E. Snedden, J. Lloyd-Smith · 2024 · PLoS Pathogens
33. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
    Xueqiao Liu, Hong-Su Park, Yumiko Matsuoka, Celia P. Santos, Lijuan Yang, Cindy Luongo, Ian N. Moore, Reed F. Johnson, Nicole L. Garza, Peng Zhang et al. · 2023 · PLoS Pathogens
34. Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys
    Hong-Zhong Yang, Wei-Gang Pan, Guoyu Chen, E. Huang, Qi-Jiong Lu, Yun-Xiang Chen, Ying Chen, Zhengbiao Yang, Lei Wen, Siming Zhang et al. · 2022 · Vaccines
35. Success of nano-vaccines against COVID-19: a transformation in nanomedicine
    M. Sarangi, S. Padhi, G. Rath, S. S. Nanda, Dong-Kee Yi · 2022 · Expert Review of Vaccines
36. COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
    A. Danchin, O. Pagani-Azizi, Gabriel Turinici, G. Yahiaoui · 2022 · Acta Biotheoretica
37. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19
    S. Tiwari, G. Goel, Ajay Kumar · 2022 · International Reviews of Immunology
38. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
39. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques
    Malika Aid, S. Vidal, C. Piedra-Mora, Sarah Ducat, Chi N. Chan, S. Bondoc, Al Colarusso, C. Starke, M. Nekorchuk, K. Busman-Sahay et al. · 2022 · PLoS Pathogens
40. Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection
    P. Doke, J. Gothankar, P. Doke, Milind Kulkarni, Kiran Kishanrao Khalate, Shubham Shrivastava, J. Patil, V. Arankalle · 2022 · Microbes and infection
41. Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
    Hui Xie, Xiaojing Wen, Juan Li, Wei-Xin Chen, Meng Chen, Lichi Zhang, M. Lv, Shan-Shan Zhou, S. Bai, Wei Zhao et al. · 2022 · International Journal of Infectious Diseases
42. Investigating SARS-CoV-2 Susceptibility in Animal Species: A Scoping Review
    C. Rutherford, Pratap Kafle, C. Soos, T. Epp, L. Bradford, E. Jenkins · 2022 · Environmental Health Insights
43. Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
    Qing Lei, Hongyan Hou, Cai-Zheng Yu, Yan-Di Zhang, Jo-Lewis Banga Ndzouboukou, Xiaosong Lin, Zongjie Yao, H. Fu, Zi-Yong Sun, Feng Wang et al. · 2021 · Journal of Immunological Research
44. SARS‐CoV‐2 and wastewater: What does it mean for non‐human primates?
    S. Mathavarajah, A. Melin, G. Dellaire · 2021 · American Journal of Primatology
45. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
    Martin Kršák, Brian L. Harry, Brent E. Palmer, Carlos Franco‐Paredes · 2021 · Viral Immunology
46. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination
    Jodi F. Hedges, Macy A Thompson, Deann T. Snyder, Amanda Robison, Matthew P. Taylor, M. Jutila · 2021 · Vaccines
47. Nonhuman primate models for SARS-CoV-2 research: Infrastructure needs for pandemic preparedness
    S. Hild, Michael C. Chang, Stephanie J. Murphy, F. Grieder · 2021 · Lab animal
48. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
49. Comparison of SARS-CoV-2 infection in two non-human primate species: rhesus and cynomolgus macaques
    K. Böszörményi, M. Stammes, Zahra C. Fagrouch, Gwendoline Kiemenyi-Kayere, H. Niphuis, D. Mortier, N. van Driel, I. Nieuwenhuis, E. Zuiderwijk-sick, L. Meijer et al. · 2020 · bioRxiv
50. SARS-CoV-2 vaccine development, access, and equity
    Jerome H. Kim · 2020 · Journal of Experimental Medicine
51. In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models
    Pei-Lan Wei, Ruo-Xi Cai, Lu Zhang, Jing-Jun Zhang, Zhao-Yong Zhang, Ai-Ru Zhu, Hai Li, Z. Zhuang, Lan Chen, Jian-Tao Chen et al. · 2025 · Emerging Microbes and Infections
52. Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
    E. Stepanova, I. Isakova-Sivak, V. Matyushenko, Daria А. Mezhenskaya, Igor Kudryavtsev, A. Kostromitina, Anna Chistiakova, A. Rak, E. Bazhenova, P. Prokopenko et al. · 2024 · Vaccines
53. Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
    Liguo Zhu, Naiying Mao, Changhua Yi, Aidibai Simayi, Jialu Feng, Yi Feng, Min Yi He, Songning Ding, Yin Wang, Yan Wang et al. · 2022 · Emerging Microbes & Infections
54. Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines
    R. Mancuso, S. Agostini, L. A. Citterio, Debora Chiarini, M. A. Santangelo, M. Clerici · 2022 · Vaccines
55. Towards the development of an epitope-focused vaccine for SARS-CoV-2
    J. Cervantes-Torres, S. Rosales-Mendoza, C. Cabello, Laura Montero, J. Hernández-Aceves, G. Granados, Arturo Calderón-Gallegos, Francisco J Zuñiga-Flores, Mirna B. Ruiz-Rivera, Julio César Abarca-Magaña et al. · 2022 · Vaccine
56. Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
    Aiquan Chang, Jing-You Yu · 2022 · Viruses
57. Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
    Ruby A. Escobedo, D. Singh, D. Kaushal · 2021 · Frontiers in Immunology
58. Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
    Xiao-Jun Tian, Wen-Guo Jiang, He Zhang, Xi-Xi Lu, Li-Bo Li, Wen-Jun Liu, Jing Li · 2021 · Frontiers in Microbiology
59. TREM2+ and interstitial macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
    Amit A. Upadhyay, T. Hoang, Maria Pino, Arun K. Boddapati, Elise G. Viox, M. Lee, Jacqueline Corry, Z. Strongin, David A. Cowan, Elizabeth N. Beagle et al. · 2021 · bioRxiv
60. Personalized Virus Load Curves for Acute Viral Infections
    Carlos Contreras, J. Newby, T. Hillen · 2021 · Viruses
61. Renal transplantation after recovery from COVID-19 - a case report with implications for transplant programs in the face of the ongoing corona-pandemic
    K. Tuschen, J. Anders, A. Elfanish, V. Schildgen, O. Schildgen, J. Becker, A. Weidemann · 2021 · BMC Nephrology
62. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population
    Michael C. Wehrhahn, S. J. Brown, James P. Newcombe, Smathi Chong, J. Evans, M. Figtree, Laurence Hainke, L. Hueston, Sadid F. Khan, E. Marland et al. · 2021 · Journal of Clinical Virology
63. Long-term sero-positivity for IgG, sequelae of respiratory symptoms, and abundance of malformed sperms in a patient recovered from severe COVID-19
    Ming-Chao Zhu, Diliang Chen, Ya Zhu, Xu-Sheng Xiong, Yan Ding, Feibo Guo, Min-Gang Zhu, Junyang Zhou · 2021 · European Journal of Clinical Microbiology and Infectious Diseases
64. COVID-19-Associated Suspected Myocarditis as the Etiology for Recurrent and Protracted Fever in an Otherwise Healthy Adult
    Ina Volis, Ido Livneh, Khetam Hussein, A. Raz-Pasteur · 2020 · American Journal of the Medical Sciences
65. Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection
    Raghu R. Chivukula, Jason H. Maley, David Michael Dudzinski, Kathryn Anne Hibbert, Charles Corey Hardin · 2020 · Journal of Intensive Care Medicine
66. Respiratory Tract Explant Infection Dynamics of Influenza A Virus in California Sea Lions, Northern Elephant Seals, and Rhesus Macaques
    Hong-Wei Liu, M. Plancarte, E. Ball, Christopher M. Weiss, Omar Gonzales-Viera, Karen M. Holcomb, Zhong-Min Ma, A. M. Allen, J. Reader, Pádraig Duignan et al. · 2020 · bioRxiv
67. Estimating the Percentage of a Population Infected with SARS-CoV-2 Using the Number of Reported Deaths: A Policy Planning Tool
    D. Feikin, M. Widdowson, K. Mulholland · 2020 · Pathogens
68. Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19
    F. Salguero, A. White, G. Slack, S. Fotheringham, K. Bewley, K. Gooch, S. Longet, H. Humphries, Robert J. Watson, L. Hunter et al. · 2020 · bioRxiv
69. Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
    T. Hoang, Maria Pino, Arun K. Boddapati, Elise G. Viox, C. Starke, Amit A. Upadhyay, S. Gumber, K. Busman-Sahay, Z. Strongin, J. Harper et al. · 2020 · bioRxiv
70. Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts
    Robert H. Bortz, Catalina Florez, E. Laudermilch, A. S. Wirchnianski, G. Lasso, Ryan J. Malonis, G. Georgiev, O. Vergnolle, Natalia G. Herrera, Nicholas C. Morano et al. · 2020 · medRxiv
71. Persistence of SARS-CoV-2 in the first trimester placenta leading to vertical transmission and fetal demise from an asymptomatic mother
    Prajakta Shende, P. Gaikwad, Manisha R. Gandhewar, Pawankumar M. Ukey, A. Bhide, V. Patel, Sharad Bhagat, Vikrant M. Bhor, S. Mahale, R. Gajbhiye et al. · 2020 · medRxiv
72. Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models
    Min-Wen Ku, M. Bourgine, Pierre Authié, Jodie Lopez, K. Nemirov, Fanny Moncoq, Amandine Noirat, B. Vesin, Fabien Névo, C. Blanc et al. · 2020 · bioRxiv
73. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters
    J. G. Diego, Gagandeep Singh, S. Jangra, Kim Handrejk, M. Laporte, Lauren A. Chang, S. E. El Zahed, L. Pache, Max W. Chang, Prajakta Warang et al. · 2024 · PLoS Pathogens
74. Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
    Guifang Chen, Xuya Yu, Liping Luo, Fan Zhang, Xia-Hong Dai, Nan Li, Zhen-Wei Shen, Kai-Qi Wu, Dan Lou, Cong-Gao Peng et al. · 2023 · Vaccine
75. A free boundary problem-in time-for the spread of Covid-19
    S. Luckhaus, Angela Stevens · 2023 · Journal of Mathematical Biology
76. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
    Xue-Qiao Liu, Hong-Su Park, Y. Matsuoka, Celia Santos, Li-Juan Yang, Cindy Luongo, Ian N. Moore, Reed F. Johnson, N. Garza, Peng Zhang et al. · 2022 · bioRxiv
77. Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes
    N. Berry, D. Ferguson, S. Kempster, Jo Hall, C. Ham, A. Jenkins, Vicky Rannow, Elaine Giles, Rose Leahy, Sara Goulding et al. · 2022 · Scientific Reports
78. The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
    Yi-Fei Wang, Qin Tian, L. Ye · 2022 · Frontiers in Cellular and Infection Microbiology
79. Animal models for studying coronavirus infections and developing antiviral agents and vaccines
    Q. Lin, Chunni Lu, Yuqi Hong, Run-Feng Li, Jin-Ding Chen, Weisan Chen, Jian-Xin Chen · 2022 · Antiviral Research
80. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects
    Ping-Ping Zhang, Bai-Sheng Li, Yao Wang, Wei Min, Xiao-Hui Wang, Yu-Gui Zhou, Zhen-Cui Li, Yong Zhao, Huan Zhang, Min Jiang et al. · 2022 · BMC Microbiology
81. Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque
    Ge Gao, Xue Hu, Yiwu Zhou, Ju-Hong Rao, Xiao-Yu Zhang, Yun Peng, Jia-Xuan Zhao, Yan-Feng Yao, Kun-Peng Liu, Mengying Liang et al. · 2022 · Virologica Sinica
82. The potential use of Drosophila as an in vivo model organism for COVID-19-related research: a review
    E. Demir · 2021 · Turkish journal of biology = Turk biyoloji dergisi
83. Impact of Prior Infection on Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Syrian Hamsters
    Cheng Zhang, Zhendong Guo, Nan Li, Huan Yong Cui, Keyin Meng, Lina Liu, Li Zhao, Shan Zhang, Cheng‐Feng Qin, Juxiang Liu et al. · 2021 · Frontiers in Microbiology
84. The relative strength and timing of innate immune and CD8 T-cell responses underlie the heterogeneous outcomes of SARS-CoV-2 infection
    Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit · 2021 · medRxiv
85. The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
    Hudachuan Jiang, Jingxin Li, Peng Zhang, X. Huo, F. Zhu · 2021 · Infectious Diseases & Immunity
86. Learning from SARS and MERS: COVID-19 reinfection where do we stand?
    J. Al-Tawfiq, A. Rabaan, A. Al-Omari, A. Al Mutair, M. Alqahtani, R. Tirupathi · 2021 · Travel Medicine and Infectious Disease
87. SARS-COV-2, can you be over it?
    A. Fiocchi, E. Jensen-Jarolim · 2021 · The World Allergy Organization Journal
88. Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future
    Tokio Hoshina, Hiroka Aonuma, Manabu Oté, T. Sakurai, E. Saiki, Y. Kinjo, K. Kondo, M. Okabe, H. Kanuka · 2020 · Inflammation and Regeneration
89. SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence.
    Sushma Boppana, Kai Qin, Jacob K. Files, Ronnie M. Russell, R. Stoltz, F. Bibollet-Ruche, A. Bansal, N. Erdmann, B. Hahn, P. Goepfert · 2020 · medRxiv
90. The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions
    S. Brown, T. Brown, P. Cederna, Rod J. Rohrich · 2020 · Plastic and Reconstructive Surgery, Global Open
91. Optimising social mixing strategies to mitigate the impact of COVID-19 in six European countries: a mathematical modelling study
    R. Ragonnet, G. Briffoteaux, Bridget M. Williams, Julian Savulescu, M. Segal, M. Abayawardana, R. Eggo, D. Tuyttens, N. Melab, B. Marais et al. · 2020 · medRxiv
92. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
    K. Freedberg, T. Baggett, J. A. Scott, Mylinh H. Le, F. Shebl, Christopher Panella, E. Losina, Clare F. Flanagan, Jessie M. Gaeta, Anne M. Neilan et al. · 2020 · medRxiv
93. A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection
    Ahmed O. Hassan, Natasha M. Kafai, I. Dmitriev, J. Fox, Brittany K. Smith, Ian B. Harvey, Rita E. Chen, Emma S. Winkler, Alex W. Wessel, J. Case et al. · 2020 · bioRxiv
94. Coronavirus Disease 2019 and Cardiac Arrhythmias
    A. Martínez-Rubio, S. Ascoeta, Fadwa Taibi, J. G. Soldevila · 2020 · European Cardiology
95. Deep Learning-Based Drug Screening for COVID-19 and Case Studies
    Konda Mani Saravanan, Haiping Zhang, Md. Tofazzal Hossain, Md. Selim Reza, Yanjie Wei · 2021 · Methods in pharmacology and toxicology
96. An overview of preclinical animal models for SARS-CoV-2 pathogenicity
    Itti Munshi, Aditya Khandvilkar, Shrinivas Chavan, G. Sachdeva, S. Mahale, U. Chaudhari · 2021 · The Indian journal of medical research
97. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
    Hadida Yasmin, Sudipta Saha, M. Butt, R. Modi, A. J. George, U. Kishore · 2021 · Advances in Experimental Medicine and Biology
98. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2.
    Manish Dhawan, Nanamika Thakur, Manish Sharma, A. Rabaan · 2025 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
99. A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
    Tian-Jiao Hao, Yu-Lei Li, Peipei Liu, Xi Wang, Ke Xu, Wen-Wen Lei, Ying Li, Rong Zhang, Xiaoyan Li, Xin Zhao et al. · 2024 · PLoS Pathogens
100. Pathogenesis of severe acute respiratory syndrome coronavirus-2 in nonhuman primates.
     Taylor Saturday, N. van Doremalen · 2023 · Current Opinion in Virology